This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hess, O. M. Articles by Sigwart, U. Search for Related Content PubMed PubMed Citation Articles by Hess, O. M. Articles by Sigwart, U.

TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY: POINT-COUNTERPOINT

New treatment strategies for hypertrophic obstructive cardiomyopathy

Alcohol ablation of the septum: the new gold standard?

Otto M. Hess, MD^*,* and Ulrich Sigwart, MD, FRCP

^* Swiss Cardiovascular Center, Bern, Switzerland
Division of Cardiology, University Hospital, Geneva, Switzerland

Manuscript received June 9, 2004; accepted August 16, 2004.

^* Reprint requests and correspondence: Dr. Otto M. Hess, Professor of Cardiology, Swiss Cardiovascular Center, University Hospital, 3010 Bern, Switzerland (Email: otto.hess{at}insel.ch).

Hypertrophic cardiomyopathy is a primary myocardial disorder with an autosomal pattern of inheritance characterized by inappropriate myocardial hypertrophy. Annual mortality has been reported to be 1% to 2% and sudden death represents the most common cause. Treatment strategies are 1) medical therapy in patients with mild to moderate symptoms, 2) reduction of septal hypertrophy by surgical myectomy or alcohol ablation, and 3) implantation of an automatic cardioverter-defibrillator in the presence of non-sustained ventricular tachyarrhythmias. A debate has been started on whether surgical myectomy or alcohol ablation of the septum is the appropriate treatment for hypertrophic obstructive cardiomyopathy. Surgical (transaortic) myectomy has been the gold standard in the past 20 to 30 years for treatment of symptomatic patients with significant hemodynamic outflow tract obstruction. However, modern interventional technologies allow reduction of the myocardial septum by injection of alcohol into the first or second septal branch under guidance of two-dimensional (2D)-contrast echocardiography. This percutaneous technique not only has a lower morbidity than surgical myectomy but can be guided precisely by 2D echocardiography. One potential complication is transient (<30%) or permanent (<10%) atrioventricular block III; however, this complication is relatively rare. A randomized trial comparing the two treatment modalities is lacking, and the chance is small that such a trial will be performed because alcohol ablation can be done with high success and low complication rates, leaving only complex interventions (with valvular reconstructions and so on) for surgical myectomy.

Abbreviations and Acronyms   HCM = hypertrophic cardiomyopathy   HOCM = hypertrophic obstructive cardiomyopathy

This article has been cited by other articles:

				N. Sreeram, M. Emmel, and J. V. de Giovanni Percutaneous Radiofrequency Septal Reduction for Hypertrophic Obstructive Cardiomyopathy in Children J. Am. Coll. Cardiol., December 6, 2011; 58(24): 2501 - 2510. [Abstract] [Full Text] [PDF]

				B. J. Maron, M. Yacoub, and J. A. Dearani Benefits of surgery in obstructive hypertrophic cardiomyopathy: bring septal myectomy back for European patients Eur. Heart J., May 1, 2011; 32(9): 1055 - 1058. [Abstract] [Full Text] [PDF]

				E. M. Aliot, W. G. Stevenson, J. M. Almendral-Garrote, F. Bogun, C. H. Calkins, E. Delacretaz, P. D. Bella, G. Hindricks, P. Jais, M. E. Josephson, et al. EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA) Europace, June 1, 2009; 11(6): 771 - 817. [Full Text] [PDF]

				O. M. Hess, W. McKenna, and H.-P. Schultheiss CHAPTER 18 Myocardial Disease ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]

				P. Sorajja, R. A. Nishimura, S. R. Ommen, C. S. Rihal, B. J. Gersh, and D. R. Holmes Jr Effect of Septal Ablation on Myocardial Relaxation and Left Atrial Pressure in Hypertrophic Cardiomyopathy: An Invasive Hemodynamic Study J. Am. Coll. Cardiol. Intv., October 1, 2008; 1(5): 552 - 560. [Abstract] [Full Text] [PDF]

				Y. Hosokawa, H. Takano, T. Ohno, M. Takayama, and T. Takano Impact of Percutaneous Transluminal Septal Myocardial Ablation on Refractory Paroxysmal Atrial Fibrillation in Patients With Hypertrophic Obstructive Cardiomyopathy Angiology, July 1, 2008; 59(3): 329 - 334. [Abstract] [PDF]

				E. Durand, E. Mousseaux, P. Coste, R. Pilliere, O. Dubourg, L. Trinquart, G. Chatellier, A. Hagege, M. Desnos, and A. Lafont Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up Eur. Heart J., February 1, 2008; 29(3): 348 - 355. [Abstract] [Full Text] [PDF]

				N. G. Smedira, B. W. Lytle, H. M. Lever, J. Rajeswaran, G. Krishnaswamy, R. K. Kaple, D. O.W. Dolney, and E. H. Blackstone Current Effectiveness and Risks of Isolated Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy Ann. Thorac. Surg., January 1, 2008; 85(1): 127 - 133. [Abstract] [Full Text] [PDF]

				R. F. Padera Jr. and F. J. Schoen Pathology of Cardiac Surgery Card. Surg. Adult, January 1, 2008; 3(2008): 111 - 178. [Full Text]

				I. Olivotto, S. R. Ommen, M. S. Maron, F. Cecchi, and B. J. Maron Surgical Myectomy Versus Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy: Will There Ever Be a Randomized Trial? J. Am. Coll. Cardiol., August 28, 2007; 50(9): 831 - 834. [Abstract] [Full Text] [PDF]

				B. J. Maron Surgical Myectomy Remains the Primary Treatment Option for Severely Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy Circulation, July 10, 2007; 116(2): 196 - 206. [Full Text] [PDF]

				M. A. Fifer Most Fully Informed Patients Choose Septal Ablation Over Septal Myectomy Circulation, July 10, 2007; 116(2): 207 - 216. [Full Text] [PDF]

				U. S. Valeti, R. A. Nishimura, D. R. Holmes, P. A. Araoz, J. F. Glockner, J. F. Breen, S. R. Ommen, B. J. Gersh, A. J. Tajik, C. S. Rihal, et al. Comparison of Surgical Septal Myectomy and Alcohol Septal Ablation With Cardiac Magnetic Resonance Imaging in Patients With Hypertrophic Obstructive Cardiomyopathy J. Am. Coll. Cardiol., January 23, 2007; 49(3): 350 - 357. [Abstract] [Full Text] [PDF]

				H. Dokainish and N. Lakkis Alcohol relaxes the stiff heart Eur. Heart J., August 1, 2006; 27(15): 1769 - 1770. [Full Text] [PDF]

				L. Salberg Treating Hypertrophic Cardiomyopathy: Two Views J. Am. Coll. Cardiol., December 6, 2005; 46(11): 2146 - 2146. [Full Text] [PDF]

				O. M. Hess and U. Sigwart Reply J. Am. Coll. Cardiol., December 6, 2005; 46(11): 2147 - 2147. [Full Text] [PDF]

				B. J. Maron, J. A. Dearani, S. R. Ommen, M. S. Maron, B. J. Gersh, and R. A. Nishimura Reply J. Am. Coll. Cardiol., December 6, 2005; 46(11): 2146 - 2147. [Full Text] [PDF]

				H. Watkins and W. J. McKenna The Prognostic Impact of Septal Myectomy in Obstructive Hypertrophic Cardiomyopathy J. Am. Coll. Cardiol., August 2, 2005; 46(3): 477 - 479. [Full Text] [PDF]